JAGX · Jaguar Health, Inc. · Investor Relations
$2.66
+0.03 (+1.14%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, along with recurring operating losses and an accumulated deficit, raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these consolidated financial statements. While management believes this infusion improves our liquidity, it does not fully alleviate the conditions that raise substantial doubt about our ability to continue as a going concern for one year from the issuance of these financial statements.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.81M
Shares
689,107
Volume · Oct 21
84.28K
Avg daily vol (3 sessions)
557.43K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-19 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-26 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-04-10 | Earnings conference call (announced in 8-K) | Earnings call |
| 2025-11-17 | Jaguar Health Investor Webcast | Webcast |